Spinal pain often arises from multiple structures within the spine. This article explains how modern biologic treatments such as platelet-rich plasma (PRP) can be integrated into a precision framework of diagnosis, treatment, image-guided delivery and rehabilitation.
Back pain is one of the most common medical problems in the world. Global epidemiological studies consistently show that low back pain is the leading cause of years lived with disability, affecting hundreds of millions of people at any given time [1,2]. Most adults will experience back pain during their lives, and the prevalence of spinal degeneration increases steadily with age.
Yet despite major advances in imaging technology, surgical techniques and interventional pain management, the core treatment pathway for chronic spinal pain has changed far less than our ability to diagnose it.
For many patients, care follows a predictable sequence: medications, injections, physiotherapy and sometimes surgery – often with fluctuating symptoms, but with the underlying tissue problem left largely unchanged.
This is important because many commonly used interventions are designed primarily to reduce inflammation or dampen pain signalling, rather than support biological repair of injured spinal structures. Epidural corticosteroid injections remain widely used, yet recent high-quality evidence has questioned their clinical impact for chronic back pain. A 2024 BMJ systematic review and meta-analysis found that spinal injections often produce only small reductions in pain and disability, with many effects falling below thresholds considered clinically meaningful for patients [3]. While these treatments can help selected individuals in specific contexts, they rarely alter the long-term trajectory of degenerative spinal disease.
Against this background, biologic therapies – including platelet-rich plasma (PRP) – have begun to attract increasing interest.
Platelet-rich plasma (PRP) is a biologic treatment created from a patient’s own blood. The process concentrates platelets into a small volume of plasma, producing a preparation with platelet levels significantly higher than baseline circulation. Platelets are biologically active cells that contain numerous growth factors and signalling molecules involved in tissue repair, angiogenesis and modulation of inflammation. When delivered to injured tissue, these factors can influence cellular activity, stimulate healing responses and support the regeneration of damaged structures. PRP therefore acts not as a drug but as a concentrated source of the body’s own biological repair signals. In musculoskeletal medicine, PRP has been widely studied for conditions such as tendon injury, cartilage degeneration and ligament damage, with systematic reviews suggesting that targeted application may improve pain and function in selected conditions [4–6]. The therapeutic rationale is straightforward: by concentrating and delivering these native healing mediators directly to injured tissue, PRP aims to support biological repair rather than simply suppress symptoms.
For readers interested in the underlying biology of platelet-rich plasma, we explain this in detail in our article “What Is PRP and How Does It Work?”
Can PRP Help Back Pain?
In selected patients, PRP injections for back pain may help reduce symptoms and support healing of injured spinal tissues. When injected precisely into structures such as degenerated discs, injured ligaments or facet joints, PRP may help modify the local tissue environment rather than simply suppress pain.
However, outcomes depend heavily on three factors:
- accurate identification of the pain generator
- precise image-guided delivery of treatment
- rehabilitation that supports healing and reduces recurrent stress
This is why spinal biologic therapies are best approached using a structured framework of diagnosis, treatment, delivery and prevention.
A Precision Framework for Treating Spinal Pain
1. Diagnosis — Identifying the True Pain Generator
2. Treatment — Addressing the Injured Tissue
3. Delivery — Why Image-Guided Precision Matters
4. Prevention — Supporting Healing and Preventing Recurrence
1. Diagnosis – Identify the True Pain Generator
Effective treatment begins with accurate diagnosis.
Spinal pain can arise from multiple structures including intervertebral discs, facet joints, ligaments, nerve roots and surrounding soft tissues. Identifying the true pain generator requires high-resolution, advanced imaging combined with clinical correlation [7].
This may include:
- High-resolution Advanced MRI to assess disc degeneration, annular injury, nerve compression and inflammatory changes
- Advanced sequences such as nerve-specific imaging or discography in selected cases
- Correlation with a structured pain map and physical examination
Without accurate diagnosis, treatment risks targeting the wrong structure.
Advanced MRI is widely accepted as the most appropriate imaging modality for evaluating the structural causes of spinal pain, including disc degeneration, nerve compression and ligament injury. However, it is important to recognise that not all MRI examinations provide the same diagnostic value. Image quality, protocol design, field strength and reporting expertise can all significantly influence the ability to detect clinically meaningful pathology.
You can read more about how to evaluate MRI quality and choose an appropriate imaging provider here.
2. Treatment – Address the Injured Tissue
Once the pathological structure is identified, treatment should be directed at the injury itself rather than simply suppressing pain.
Conventional spinal interventions such as corticosteroid injections primarily act through anti-inflammatory effects, which can temporarily reduce pain and nerve irritation. However, these treatments do not directly promote structural repair of injured discs, ligaments or joint tissues, and therefore may relieve symptoms without addressing the underlying tissue pathology.
For this reason, increasing attention has turned toward cellular and biologic therapies designed to influence tissue healing. These include platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC) and other cell-based approaches that aim to modify the biological environment within injured spinal structures.
Among these, platelet-rich plasma is one of the most widely studied biologic treatments in musculoskeletal medicine. Platelets contain a concentrated reservoir of growth factors and signalling molecules involved in:
- tissue repair
- angiogenesis
- modulation of inflammatory pathways
These biological processes are central to the healing response in tissues [4-6,8].
Emerging clinical studies suggest PRP injections for back pain may provide benefit in carefully selected patients with degenerative disc disease, discogenic pain, facet joint pathology and ligament injury, with several trials reporting improvements in pain and function following targeted injection of PRP into the affected spinal structure [9–11].
3. Delivery — Precision Matters
Even the most promising therapy will fail if it is delivered inaccurately.
The spine contains small, complex anatomical targets including intervertebral discs, facet joints, neural foramina, ligaments and the epidural space. Successful treatment therefore depends on accurate needle placement within the pathological structure.
Traditionally, spinal injections have been performed under fluoroscopic or CT guidance, which allow direct visualisation of bony landmarks and precise positioning of the needle relative to critical neural structures. These techniques remain widely used because they provide reliable anatomical guidance for deep spinal targets. Real-time CT guidance in particular allows cross-sectional visualisation of the needle trajectory and surrounding structures, improving procedural targeting and accuracy [12].
Evidence suggests that enhanced imaging guidance can improve procedural outcomes. For example, CT-guided lumbar facet injections have been shown to produce greater diagnostic accuracy and larger reductions in pain compared with conventional fluoroscopic techniques, likely reflecting improved specificity of needle placement [13].
More recently, MRI-guided spinal interventions have also been explored. MRI offers superior soft-tissue contrast and multiplanar visualisation, allowing detailed depiction of nerve roots, spinal cord and surrounding structures while avoiding ionising radiation. These characteristics make MRI an attractive guidance modality for certain spinal interventions, although the need for specialised equipment and procedural infrastructure currently limits widespread adoption [14].
Ultrasound guidance has also been introduced for selected spinal procedures. Ultrasound can be useful in musculoskeletal injections and offers the advantage of avoiding ionising radiation. However, when applied to deep spinal structures its accuracy can be more variable and is often highly operator dependent, particularly where overlying bone limits direct visualisation of the target anatomy [15,16].
In practice, clinicians often work with the tools available within their clinical environment. In settings where ultrasound is the only imaging modality available, it may become the default guidance technique.
However, spinal anatomy is complex, and even small deviations in needle placement can result in treatment being delivered adjacent to – rather than directly into – the pathological structure.
Radiology-based procedural environments typically have access to the full spectrum of image-guidance technologies, including CT, fluoroscopy and ultrasound. This allows the most appropriate modality to be selected for each procedure in order to maximise anatomical visualisation and procedural precision.
In addition, regulatory and professional standards require that a permanent record of final needle position be documented as part of the procedural record. Imaging confirmation therefore provides an important layer of safety, ensuring accurate targeting while maintaining a verifiable record of treatment delivery.
For biologic therapies such as platelet-rich plasma (PRP), where the goal is to deliver a regenerative signal directly to injured tissue, accurate targeting of the pathological structure becomes particularly important.
Image-guided spinal procedures have consistently been shown to improve injection accuracy compared with landmark-based techniques [16]. In the spine, where injections occur in close proximity to nerve roots, the spinal cord and vascular structures, landmark-based techniques without imaging guidance carry a substantial risk of inaccurate needle placement and non-target injection. Consequently, modern interventional spine practice strongly favours the use of imaging guidance with digital record keeping to maximise procedural safety and precision.
4. Prevention — Support Healing and Reduce Recurrence
Treatment does not end with the injection.
Even when biologic therapies successfully reduce pain and support tissue repair, the mechanical environment of the spine remains a critical determinant of long-term outcomes. Many spinal disorders arise from a combination of tissue injury and repetitive biomechanical stress. If those stresses are not addressed, the same structures can become injured again.
For this reason, regenerative treatments are best viewed as one component of a broader structural rehabilitation strategy.
Following biologic treatment, many patients benefit from a structured recovery program designed to restore normal spinal mechanics and reduce excessive loading on injured tissues. This may include:
- targeted physiotherapy and progressive rehabilitation
- retraining of movement patterns and posture
- strengthening of deep spinal stabilising muscles
- optimisation of core and hip biomechanics
- gradual return to physical activity
In selected cases, follow-up imaging may also be used to assess structural changes within the treated tissue and to guide progression of rehabilitation.
The goal of this phase is not simply symptom control, but restoration of a mechanical environment that allows healing tissues to remain stable over time.
When diagnosis, biologic treatment and rehabilitation are aligned, the aim is not only to reduce pain, but to improve the long-term resilience of the spinal structures themselves.
Who May Be a Candidate for PRP Treatment in the Spine?
PRP treatment may be considered in carefully selected patients with conditions such as:
- discogenic back pain
- facet joint degeneration
- ligament injury or instability
- early degenerative disc disease
- persistent pain despite appropriate conservative therapy
Suitability depends on confirming the pain generator and excluding red flags that require urgent medical or surgical care. Accurate diagnosis using advanced imaging and clinical correlation remains essential before considering regenerative therapies [7].
Conclusion
Spinal pain is not one diagnosis. It is a symptom that can arise from multiple structures – discs, facet joints, ligaments, nerve roots and surrounding soft tissues – and often more than one contributor exists at the same time. That complexity is exactly why broad, non-specific treatments so often disappoint: they may reduce symptoms temporarily, but they can miss the true pain generator and rarely change the biology of degeneration.
Biologic therapies such as PRP are appealing because they represent a different intent. Rather than simply turning pain down, the goal is to influence the local tissue environment and support repair processes. The emerging clinical literature suggests that, in carefully selected patients, PRP may offer meaningful benefit in conditions such as discogenic pain, facet pathology and ligament injury [9–11].
But the real message of this article is that biologic therapy is only as good as the system around it.
If the diagnosis is wrong, the treatment is misdirected.
If the needle placement is imprecise, the biologic signal may never reach the target.
And if rehabilitation is not aligned with the mechanics that caused the injury, the same problem can return.
This is why spinal regeneration should not be reduced to “an injection.” It should be approached as a precision framework:
- Diagnosis to identify the true pain generator.
- Treatment aimed at tissue biology, not just symptom suppression.
- Delivery that matches spinal complexity with high-fidelity image guidance and records what was done.
- Prevention through rehabilitation that protects healing tissue and reduces recurrence.
- When those components are aligned, the goal shifts from short-term pain control to something far more valuable: genuine tissue healing, improved spinal stability, and a return to normal function.
Author: Dr Kirralee Sherif (PhD)
Related Articles
- What Is PRP and How Does It Work?
- Why Platelet Count Matters in PRP Therapy: The Science Behind Effective Platelet-Rich Plasma
- How to Choose a High-Quality MRI Provider
- Does Medicare Cover PRP?
FAQ
Can PRP injections help back pain?
Platelet-rich plasma (PRP) injections are increasingly being studied for conditions such as discogenic back pain, facet joint degeneration and ligament injury. By delivering concentrated growth factors directly to injured tissue, PRP aims to influence the biological environment of the spine and support healing rather than simply suppress symptoms. Clinical studies suggest that carefully selected patients may experience improvements in pain and function following PRP injection therapy.
How does PRP work in the spine?
PRP contains a concentrated reservoir of platelets and growth factors that play a role in tissue repair, angiogenesis and inflammatory regulation. When injected into injured spinal structures such as discs, ligaments or facet joints, these signalling molecules may stimulate cellular activity and influence the healing environment within the tissue.
Are spinal injections safe?
Image-guided spinal injections are widely used in modern interventional medicine. When performed using appropriate imaging guidance such as CT, the needle can be accurately positioned relative to important anatomical structures including nerves and blood vessels. Imaging confirmation of needle placement is an important safety step in modern spinal procedures.
Is PRP better than cortisone injections?
Corticosteroid injections primarily act by reducing inflammation and suppressing pain signals. PRP works differently. Rather than suppressing symptoms, PRP aims to influence the biological environment of injured tissues and support healing processes. These treatments therefore have different purposes and may be appropriate in different clinical situations.
How many PRP injections are needed for back pain?
Treatment plans vary depending on the pain generator, the severity of tissue degeneration and response to the first injection. Some patients may improve after a single treatment, while others may require a series. The most important determinant is accurate diagnosis and precise delivery into the pathological structure, followed by rehabilitation that supports healing.
Do all spinal injections require imaging guidance?
Modern interventional spine practice strongly favours image-guided procedures. Techniques such as CT, fluoroscopy or ultrasound allow clinicians to visualise anatomical structures and guide needle placement accurately. This reduces the risk of incorrect targeting and helps ensure treatment is delivered to the intended structure.
References
3. Busse JW, Genevay S, Agarwal A, Standaert CJ, Carneiro K, Friedrich J, et al. Commonly used interventional procedures for non-cancer chronic spine pain: a clinical practice guideline. BMJ. 2025;388:e079970. doi:10.1136/bmj-2024-079970.
4. Tischer T, Bode G, Buhs M, Marquass B, Nehrer S, Vogt S, et al. Platelet-rich plasma (PRP) as therapy for cartilage, tendon and muscle damage: German Working Group position statement. J Exp Orthop. 2020;7(1):64. doi:10.1186/s40634-020-00282-2.
5. Fitzpatrick J, Bulsara M, Zheng MH. The Effectiveness of Platelet-Rich Plasma in the Treatment of Tendinopathy: A Meta-analysis of Randomized Controlled Clinical Trials. Am J Sports Med. 2017 Jan;45(1):226-233. doi: 10.1177/0363546516643716. Epub 2016 Jul 21. PMID: 27268111.
6. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225-8. doi: 10.1097/00008505-200110000-00002. PMID: 11813662.
7. Balza R, Mercaldo SF, Chang CY, Huang AJ, Husseini JS, Kheterpal AB, Simeone FJ, Palmer WE. Impact of Patient-Reported Symptom Information on Agreement in the MRI Diagnosis of Presumptive Lumbar Spine Pain Generator. AJR Am J Roentgenol. 2021 Oct;217(4):947-956. doi: 10.2214/AJR.20.25210. Epub 2021 Jan 13. PMID: 33438459.
8. Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013 Dec;9(12):721-30. doi: 10.1038/nrrheum.2013.141. Epub 2013 Oct 1. PMID: 24080861.
9. Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, Nguyen JT, Solomon JL, Lutz GE. Lumbar Intradiskal Platelet-Rich Plasma (PRP) Injections: A Prospective, Double-Blind, Randomized Controlled Study. PM R. 2016 Jan;8(1):1-10; quiz 10. doi: 10.1016/j.pmrj.2015.08.010. Epub 2015 Aug 24. PMID: 26314234.
10. Hirase T, Jack Ii RA, Sochacki KR, Harris JD, Weiner BK. Systemic Review: Is an Intradiscal Injection of Platelet-Rich Plasma for Lumbar Disc Degeneration Effective? Cureus. 2020 Jun 25;12(6):e8831. doi: 10.7759/cureus.8831. PMID: 32607308; PMCID: PMC7320640.
11. Machado ES, Soares FP, Vianna de Abreu E, de Souza TADC, Meves R, Grohs H, Ambach MA, Navani A, de Castro RB, Pozza DH, Caldas JMP. Systematic Review of Platelet-Rich Plasma for Low Back Pain. Biomedicines. 2023 Aug 28;11(9):2404. doi: 10.3390/biomedicines11092404. PMID: 37760845; PMCID: PMC10525951.
12. Fritz J, Niemeyer T, Clasen S, Wiskirchen J, Tepe G, Kastler B, Nägele T, König CW, Claussen CD, Pereira PL. Management of chronic low back pain: rationales, principles, and targets of imaging-guided spinal injections. Radiographics. 2007 Nov-Dec;27(6):1751-71. doi: 10.1148/rg.276065509. PMID: 18025516.
13. Meleka S, Patra A, Minkoff E, Murphy K. Value of CT fluoroscopy for lumbar facet blocks. AJNR Am J Neuroradiol. 2005 May;26(5):1001-3. PMID: 15891151; PMCID: PMC8158632.
14. Himes NC, Chansakul T, Lee TC. Magnetic Resonance Imaging-Guided Spine Interventions. Magn Reson Imaging Clin N Am. 2015 Nov;23(4):523-32. doi: 10.1016/j.mric.2015.05.007. Epub 2015 Jul 6. PMID: 26499272; PMCID: PMC5330180.
15. Tay M, Sian SCSH, Eow CZ, Ho KLK, Ong JH, Sirisena D. Ultrasound-Guided Lumbar Spine Injection for Axial and Radicular Pain: A Single Institution Early Experience. Asian Spine J. 2021 Apr;15(2):216-223. doi: 10.31616/asj.2019.0399. Epub 2020 Sep 3. PMID: 32872762; PMCID: PMC8055452.
16. Shen PC, Lin TY, Wu WT, Özçakar L, Chang KV. Comparison of ultrasound- vs. landmark-guided injections for musculoskeletal pain: an umbrella review. J Rehabil Med. 2024 Aug 26;56:jrm40679. doi: 10.2340/jrm.v56.40769. PMID: 39185547; PMCID: PMC11367678.
